====== Conjunctival Pigmented Lesions ====== ====Nevi==== * Usually appear in childhood * Maybe pigmented or non-pigmented * May become more pigmented with puberty or pregnancy * Appearance * well circumscribed * cystic spaces * Vascular supply * Categorized histologically as * Junctional * Compound * Subepithelial ====Lesions arising from melanocytes==== ===Complexion Associated Melanosis (CAM)=== * Bilateral perilimbal pigmentation in darkly pigmented inviduals * Doesn't progress to melanoma ===Primary Acquired Melanosis (PAM)=== * Usually seen in fair skinned middle aged or older * flat, unilateral, patchy, golden yellow or brown area, which may extend onto the cornea or corneal may similarly be involved. * PAM with atypia can progress to melanoma * PAM without atypia is low to no risk of transformation * Treatement * smaller lesions can be monitored, watching for nodularity, thickening, vascularity * if changes or larger lesion, excision is recommended * Excision * Margins 4-5 mm * Double freeze-thaw slow cryotherapy applied to the conjunctival edges * For corneal PAM, apply absolute alcohol for one minute then epitheliectomy * For diffuse disease or tarsal conjunctiva * Cryotherapy with double freeze-thaw * Topical interferon alpha-2b * Topical mytomycin C 0.02% or 0.04% * QID x 1 week * Pause 1-2 weeks * then QID x 1 week * Repeat above until the pigment resolves, usually for 2-3 cycles * punctual plugs placed before treatment * use artificial tears and topical steroids for corneal toxicity ===Malignant Melanoma=== * Patients are usually 60-70 years old * Limbus most common but can appear in the caruncle, tarsus or fornix * Raised mass with feeder vessels * Treatment * Avoid incisional biopsy to prevent tumor seeding * Excision with dry no-touch technique with margins of 4-6 mm * Cryotreatment to conjunctival edges with double freeze-thaw * Absolute alcohol to corneal lesions with * Sclerectomy may be needed for tumors adherent to the sclera applying cautery and cryotherapy to the base * Closure with primary closure or amniotic graft to cover the defects * Sentinel node biopsy should be considered for lesions larger than 2 mm or high risk features on histopathology * Prognosis * Local recurrence 45% at 5 years and 59% at 10 years * Mortality: 5-17% at 5 years- 9-35% at 10 years * Denovo lesions have worst prognosis * Poorer survival: older age, male, non-white, tumors with nodularity or ulceration. ====Summary Table==== ^ Type ^ History ^ Color ^ Appearance ^ Laterality ^ Specific Features ^ Chance of Maligancy ^ Primary Management ^ ^ Nevus | Onset in childhood | Iight brown or non-pigmented | slightly raised and cystic with well defined margins | most unilateral and solitary | pigmentation changes with puberty and pregnancy | rare | Photograph and observe every 6-12 months | ^ CAM | In darkly pigmented individuals, can increase with age | Brown | flat, non-cystic, diffuse, will-defined margins, usually prominent around limbus | bilateral | can be extensive | rare | Photograph and observe every 6-12 months | ^ PAM | Newly pigmented | light to dark brown | flat, diffuse and non-cirumscribed | unilateral, usually in those with lighter skin color | waxing and waning of size and pigmentation | 50% with cellular atypia | If larger than 2 clock hours: wide excision with cryotherapy, if not possible map biopsy | ^ Melanoma | Denovo or arises from previous lesion above | dark brown but may be amelanotic or mixed pigmentation | elevated, thickened, nodular | unilateral | highly vascular with feeder vessel often | 35% develop metastasis by 5 years | Complete excision with cryotherapy, metastatic workup | ====Resources==== - [[https://www.aao.org/eyenet/article/conjunctival-pigmented-lesions-diagnosis-managemen |Conjunctival Pigmented Lesions: Diagnosis and Management. Sayaad FFE et al. Eyenet September 2013]] - [[https://pubmed.ncbi.nlm.nih.gov/14711437/ |Tumors of the conjunctiva and cornea. Shields CL, Shields JA. Surv Ophthalmol. 2004;49(1):3-24]] - [[https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S003962572200039X?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS003962572200039X%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F| Use of interferon alpha 2b to manage primary acquired melanosis and conjunctival melanoma. Cid-Bertomeu P, et al. Surv Ophthalmol. 2022;67(5):1391-1404]]